You are here: Industry Insights > vision

News List

FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC americanpharmaceuticalreview
February 09, 2021
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tepotinib (Tepmetko, EMD Serono Inc.) for adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping ...
FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations prnasia
February 04, 2021
Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has approved TEPMETKO® (tepotinib) following Priority Review for the treatment of adult patients with metastatic non-small cell lung cancer ...
Fatty Diets Tied to Leading Cause of Vision Loss in Seniors drugs
December 27, 2019
Diets heavy in red meat and fatty foods could help spur a leading cause of vision loss in older Americans, new research suggests.
Antares Vision Offers Traceability Solution contractpharma
August 01, 2019
“TrackMyWay” provides supply chain transparency and customer engagement.
IPA releases Vision 2030 for Indian Pharma Industry expressbpd
June 27, 2019
The report is based on a research collaboration with McKinsey & Company and takes inputs from the IPA members and industry leaders
Impaired Vision Tied to Perceived Discrimination in Older Adults drugs
June 03, 2019
Impaired Vision Tied to Perceived Discrimination in Older Adults.
Antares Vision Introduces Data Monitoring System contractpharma
May 16, 2019
New AVionics solution utilizes data collected for serialization compliance to help improve production practices and line speeds.
ICMR published its strategic plan and vision for 2030 expressbpd
October 13, 2017
The research body in collaboration with MoH&FW has awarded 86 scientists for finding solutions to important health challenges and for their contribution in bio-medical science research